| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 11/24/2005 | US20050261472 Binding moieties for fibrin |
| 11/24/2005 | US20050261270 Modified beta-lactamases and uses thereof |
| 11/24/2005 | US20050261265 modulating cellular senescence in vitro by introducing a polynucleotide (gDNA or cDNA) encoding an amphiphysin-1 protein; genetic engineering; genetic disorders, premature aging |
| 11/24/2005 | US20050261252 LPA receptor agonists and antagonists and methods of use |
| 11/24/2005 | US20050261249 administering antisense oligonucleotides comprising nuclease resistant backbones and targeting sequences which forms heteroduplex with target region of processed human RNA transcripts affecting expression of proteins and inhibits expression of active proteins in target cancer cells |
| 11/24/2005 | US20050261235 2' ,5' -Oligoadenylate analogs |
| 11/24/2005 | US20050261234 GFAP-based gene therapy for treatment of retinal diseases |
| 11/24/2005 | US20050261233 Modulation of glucose-6-phosphatase translocase expression |
| 11/24/2005 | US20050261231 Improving tissue survival; methods for enhancing organ transplant, musculocutaneous flap or skin graft survival by administering a nucleic acid sequence encoding hepatocyte growth factor; neovascularization; surgery; tissue-targeted therapy |
| 11/24/2005 | US20050261230 Method for the prophylaxis and/or treatment of medical disorders |
| 11/24/2005 | US20050261229 Fc fusion proteins for enhancing the immunogenicity of protein and peptide antigens |
| 11/24/2005 | US20050261228 Polynucleotide; diagnosis, therapy of Crohn's disese, encephalomyelitis, antitumor agents; modulate interleukins |
| 11/24/2005 | US20050261226 Methods and compositions for the treatment of cancer with oligonucleotides directed against Egr-1 |
| 11/24/2005 | US20050261225 Peptides that deliver antisense oligonucleotides which downregulate protein expression in cells |
| 11/24/2005 | US20050261224 Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 function |
| 11/24/2005 | US20050261222 Oligoribonucleotides for the treatment of irritative or inflammatory skin symptoms through RNA interference |
| 11/24/2005 | US20050261221 Compositions and methods for enhanced delivery of compounds via transfection complexes |
| 11/24/2005 | US20050261219 RNA interference mediated inhibition of interleukin and interleukin receptor gene expression using short interfering nucleic acid (siNA) |
| 11/24/2005 | US20050261218 Oligomeric compounds and compositions for use in modulation small non-coding RNAs |
| 11/24/2005 | US20050261217 Modulation of pumilio 1 expression |
| 11/24/2005 | US20050261216 Modulation of Nanos 1 expression |
| 11/24/2005 | US20050261214 Complexes for transferring substances of interest into a cell |
| 11/24/2005 | US20050261212 RNA interference mediated inhibition of NOGO and NOGO receptor gene expression using short interfering RNA |
| 11/24/2005 | US20050261193 Antimicrobial theta defensins and methods of using same |
| 11/24/2005 | US20050261192 Novel polypeptide and its DNA |
| 11/24/2005 | US20050261188 Genes encoding proteins with pesticidal activity |
| 11/24/2005 | US20050261187 Methods and compositions relating to MEK5 and cardiac hypertrophy and dilated cardiomyopathy |
| 11/24/2005 | US20050261186 NRG-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 11/24/2005 | US20050261183 PTHrP-derived modulators of smooth muscle proliferation |
| 11/24/2005 | US20050260767 Treatment with cytokines |
| 11/24/2005 | US20050260759 Transforming fungus (Fusarium oxysporum) with a polynucleotide comprising inactivated marker gene; controlling expression of transposase; insertional mutagenesis and tagging |
| 11/24/2005 | US20050260758 High efficiency peptide production in plant cells |
| 11/24/2005 | US20050260756 Complex for facilitating delivery of dsRNA into a cell and uses thereof |
| 11/24/2005 | US20050260755 Sequential delivery of oligomeric compounds |
| 11/24/2005 | US20050260754 Constructs and methods for the regulation of gene expression |
| 11/24/2005 | US20050260747 Embryonic stem cells and neural progenitor cells derived therefrom |
| 11/24/2005 | US20050260746 Transgenic pig containing heat shock protein 70 transgene |
| 11/24/2005 | US20050260739 Comprising a disrupted ACR3 gene; treating waste water containing heavy metal ion such as As; pollution control |
| 11/24/2005 | US20050260736 Using high speed fluorescence activated cell sorting (FACS) to isolate bacterial cells expressing ligand binding polypeptides |
| 11/24/2005 | US20050260734 Packaging cells |
| 11/24/2005 | US20050260732 Polypeptide crystal having a polyhistidine tag added to the C-terminal end; effectors; drug screening for enzyme inhibitors; multiple sclerosis, diabetes, Grave's disease, rheumatic arthritis, AIDS, cancer, immunomodulators |
| 11/24/2005 | US20050260731 Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy |
| 11/24/2005 | US20050260729 Method of engineering a cytidine monophosphate-sialic acid synthetic pathway in fungi and yeast |
| 11/24/2005 | US20050260728 Polypeptides; genetic engineering; acinetobacter culture product |
| 11/24/2005 | US20050260726 Novel human protease inhibitor and polynucleotides encoding the same |
| 11/24/2005 | US20050260725 Process for the preparation of trans-carveol |
| 11/24/2005 | US20050260722 Ascorbic acid production from yeast |
| 11/24/2005 | US20050260721 Method for zymotic production of fine chemicals (mety) containing sulphur |
| 11/24/2005 | US20050260717 Double transdominant fusion gene and protein |
| 11/24/2005 | US20050260716 Non-immunoglobulin polypeptide, linker and dimerizing domain; cell-surface receptors; signal transduction |
| 11/24/2005 | US20050260715 Efficient methods for producing antimicrobial cationic peptides in host cells |
| 11/24/2005 | US20050260712 Process for preparing dipeptidyl peptidase IV inhibitors and intermediates therefor |
| 11/24/2005 | US20050260710 Methods for producing recombinant polyclonal immunoglobulins |
| 11/24/2005 | US20050260709 Lipin1 function |
| 11/24/2005 | US20050260708 Proteases and protease inhibitors |
| 11/24/2005 | US20050260707 Corynebacterium glutamicum genes encoding metabolic pathway proteins |
| 11/24/2005 | US20050260705 Methods and cells for expression of recombinant protein products under the transcriptional control of an inducible promoter |
| 11/24/2005 | US20050260702 Novel integrin alpha subunit and uses thereof |
| 11/24/2005 | US20050260699 Carotenoid biosynthesis |
| 11/24/2005 | US20050260687 DNA encoding mammalian neuropeptide FF (NPFF) receptors and uses thereof |
| 11/24/2005 | US20050260681 Recovering autoantibodies/blood protein via adjustment in redox states for use in constructing profile for diagnosing autoimmune disorders; immunotherapy; antioxidant |
| 11/24/2005 | US20050260675 Useful in identifying and designing novel Bt toxin receptor ligands including novel insecticidal toxins; manipulating Bt toxin susceptibility in plant pests |
| 11/24/2005 | US20050260674 Specific polypeptides, useful as nematocides |
| 11/24/2005 | US20050260673 nematode-specific gene products that can serve as targets for inhibitory peptides and proteins (e.g., antibodies) and antiparasitic chemicals |
| 11/24/2005 | US20050260670 Novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereof |
| 11/24/2005 | US20050260669 Antibodies to iron regulating protein -2 (IRP-2) as a diagnostic for neurodegenerative disease |
| 11/24/2005 | US20050260668 Novel compounds |
| 11/24/2005 | US20050260667 determining the predisposition of individuals to schizophrenia, bipolar disorder and mental disorders; drug screening; reduced side effects |
| 11/24/2005 | US20050260657 Molecular entity for controlling a calcium |
| 11/24/2005 | US20050260655 Rearrangement of nucleotide sequences; obtain nucleotide sequences, incubate with ligase, ligate, recover and analyze nucleotide sequence product; used to diversify proteins |
| 11/24/2005 | US20050260652 Compositions and methods that modulate RNA interference |
| 11/24/2005 | US20050260648 Method for the determination of cellular transcriptional |
| 11/24/2005 | US20050260644 Cell signaling proteins |
| 11/24/2005 | US20050260643 Cancer specific promoters |
| 11/24/2005 | US20050260642 CNGH0011 polynucleotides, polypeptides, antibodies, and compositions, and methods of production and use |
| 11/24/2005 | US20050260641 Methods for DNA recovery |
| 11/24/2005 | US20050260638 Methods for detecting nucleic acids indicative of cancer |
| 11/24/2005 | US20050260637 Drug screening |
| 11/24/2005 | US20050260632 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 11/24/2005 | US20050260631 Method of amplifying nucleic acids, reagent kit for amplifying nucleic acids, method of detecting single nucleotide polymorphism, and reagent kit for detecting single nucleotide polymorphism |
| 11/24/2005 | US20050260626 In vivo production of cyclic peptides for inhibiting protein-protein interaction |
| 11/24/2005 | US20050260622 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 11/24/2005 | US20050260621 Immunoreactive 38-KDA ferric binding protein of ehrlichia canis and uses thereof |
| 11/24/2005 | US20050260620 Hearing loss, deafness, tinnitus, motion and balance disorders, cancer and proliferative diseases |
| 11/24/2005 | US20050260617 Oligo-or polynucleotides |
| 11/24/2005 | US20050260616 Nucleotide and protein sequences of Nogo genes and methods based thereon |
| 11/24/2005 | US20050260614 Methods for real-time single molecule sequence determination |
| 11/24/2005 | US20050260612 Chemical treatment for removing cellular and nuclear material from naturally occurring extracellular matrix-based biomaterials |
| 11/24/2005 | US20050260605 Targeting of genetic vaccine vectors |
| 11/24/2005 | US20050260604 Antigens derived from the core protein of the human mammary epithelial mucin |
| 11/24/2005 | US20050260601 Recombinant mutants of rhabdovirus and methods of use thereof |
| 11/24/2005 | US20050260600 Amino radicals; magnetic bodies, metals, plastic and glass beads or gel; increased recovery ratio |
| 11/24/2005 | US20050260599 Nucleic acid and amino acid sequences of sweet taste receptors comprising two heterologous G-protein coupled receptor polypeptides; screening for modulators; probes for the identification of taste cells |
| 11/24/2005 | US20050260598 Novel clot-specific streptokinase proteins possessing altered plasminogen activation characteristics and a process for the preparation of said protein |
| 11/24/2005 | US20050260597 Transfection reagents |
| 11/24/2005 | US20050260596 Packaging systems for human recombinant adenovirus to be used in gene therapy |
| 11/24/2005 | US20050260590 Yeast-origin promoter and vector and expression system using the same |
| 11/24/2005 | US20050260588 In vivo ssdna expression vectors for altering gene expression |
| 11/24/2005 | US20050260587 Synthetic transfer complex and method for transferring nucleic acids |
| 11/24/2005 | US20050260585 Poison/antidote genetic systems for the selection of genetically modified eucaryote cells or organisms |